The FDA has approved Bravnetsa (lutetium Lu 177 dotatate) via the ANDA pathway as a bioequivalent treatment option for SSTR-positive GEP-NETs.
Endometriosis macrophenotypes exhibit distinct risk factor profiles and comorbidity patterns, suggesting varying disease etiologies.
Isolated diastolic hypertension in young adults is associated with an increased risk for atherosclerotic cardiovascular disease and heart failure.
IBD is not associated with increased risk for hypertensive disorders of pregnancy, but is associated with increased risk for preeclampsia.